H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium — Tampa, Florida

H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium has participated in 1 clinical trials.

Therapeutic areas: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blastic Phase Chronic Myelogenous Leukemia.

Sponsors: Fred Hutchinson Cancer Center.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium?

H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium conducted?

H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium has 1 clinical trials on record. Their work covers Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blastic Phase Chronic Myelogenous Leukemia.

Is H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium accredited by Crixeo Health?

H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.